March 19, 2018 / 10:27 AM / 7 months ago

BRIEF-Granules India Says U.S. FDA Approves ANDA For Metformin Extended Release Tablets

1 Min Read

March 19 (Reuters) - Granules India Ltd:

* USFDA APPROVED ANDA FILED BY CO FOR METFORMIN EXTENDED RELEASE (ER) TABLETS 500 MG AND 750 MG

* SAYS CO INTENDS TO COMMERCIALISE PRODUCT SHORTLY Source text - bit.ly/2GIAtXh Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below